Park K, Jnne PA, Kim DW, Han JY, et al. Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study. Cancer 2021 Jan 12. doi: 10.1002/cncr.33385.
PMID: 33434335